Haematological Tumours Haematological tumours have a different specificity compared to solid tumors. Knowledge of their epidemiological indicators (incidence, mortality, survival, etc.) by tumour subtype is of great interest to both clinicians and epidemiologists. This objective is developed primarily through the “Haematological Tumours/HematoRedecan” Working Group. The members of the HematoRedecan Working Group can be found in Activities and results/Working Groups/Hematological Tumours-HematoRedecan
